Compare PPIH & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPIH | KRRO |
|---|---|---|
| Founded | 1909 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.6M | 187.9M |
| IPO Year | 1994 | 2019 |
| Metric | PPIH | KRRO |
|---|---|---|
| Price | $30.90 | $9.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | ★ $36.00 | $34.80 |
| AVG Volume (30 Days) | 82.2K | ★ 165.5K |
| Earning Date | 04-16-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.61 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | N/A | ★ $6,392,000.00 |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $9.33 | N/A |
| P/E Ratio | $58.19 | ★ N/A |
| Revenue Growth | N/A | ★ 181.46 |
| 52 Week Low | $22.13 | $5.20 |
| 52 Week High | $36.72 | $55.89 |
| Indicator | PPIH | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 62.51 | 35.18 |
| Support Level | $30.05 | $8.38 |
| Resistance Level | $31.80 | $14.69 |
| Average True Range (ATR) | 1.06 | 1.23 |
| MACD | 0.04 | -0.38 |
| Stochastic Oscillator | 64.02 | 12.67 |
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems of the company include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, the coating and insulation of oil and gas gathering and transmission pipelines, and liquid and powder based anti-corrosion coatings applied both to the external and internal surfaces of steel pipe, including shapes such as bends, reducers, tees, and other fittings.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.